Phibro Animal Health Corporation (PAHC)
The company now
Phibro Animal Health Corporation is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Teaneck, NJ. In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported revenue of $1.5 billion and a profit of $100 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2026, as filedRevenue by line of business, fiscal 2026
| Line of business | Fiscal 2026 | Fiscal 2025 | Share of revenue |
|---|---|---|---|
| Animal Health | $1.16B | $963M | 76.6% |
| Mineral Nutrition | $282M | $253M | 18.6% |
| Performance Products | $73.5M | $80.2M | 4.8% |
Revenue by region, fiscal 2026
| Region | Fiscal 2026 | Fiscal 2025 | Share of revenue |
|---|---|---|---|
| United States | $877M | $740M | 57.8% |
| Latin America and Canada | $341M | $299M | 22.4% |
| Europe, Middle East and Africa | $188M | $160M | 12.4% |
| Asia Pacific | $112M | $97.4M | 7.4% |
As tagged in its annual report (Form 10-K, filed Aug 26, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.